elevidys fda - Search News

Order byBest matchMost fresh

FDA, Sarepta Therapeutics and gene

· 4h · on MSN

Sarepta shares slide again as drugmaker bows to FDA pressure to pause gene therapy

Shares of drugmaker Sarepta Therapeutics continued to sink Tuesday after the company said it would comply with a Food and Drug Administration request to pause shipments of its gene therapy following s...

Continue reading

· 3d · on MSN

Sarepta says it won't comply with FDA request to stop shipping gene therapy Elevidys

Sarepta Concedes to FDA Request, Suspends US Shipments of Elevidys

Sarepta Faces Fresh Setback. Why Now’s Not the Time to Buy the Stock.

Sarepta Therapeutics was falling again in premarket trading Tuesday as its future looks increasingly shaky after it agreed to halt shipments of its Elevidys drug under pressure from the Food and Drug ...

Continue reading

In surprise reversal, Sarepta Therapeutics says it will pause shipments of Duchenne gene therapy

Pharmalittle: We’re reading about Sarepta resisting FDA over Elevidys, agency naming top drug regulator, and more

1d

Sarepta Therapeutics stock sinks after FDA tells company to stop shipping its bestselling drug

Sarepta stock tanked Friday after a new patient death was uncovered, spurring an FDA request to halt shipments of an unrelated drug.